#Sanitation | With COVID-19 revealing the stark realities of urban India, there is an acute need to restructure urban sanitation servicing and operations for, by, and with the community that it is meant for.
India's vaccine maker Bharat Biotech said Wed its #covid19 #vaccine #Covaxin has demonstrated 81% interim efficacy in preventing COVID-19 in those without prior infection after the second dose, according to Phase 3 trial results.
India’s COVID-19 vaccine produced by Bharat Biotech shows 81% efficacy
Significant disruptions to supplies of APIs from China caused by the COVID-19 pandemic have led India to fundamentally rethink its supply chains and the structure of its pharmaceutical industry, according to industry executives and consultants.
Made in India COVID-19 vaccines land in Kigali, the capital city of Rwanda Catch the day's latest news and updates:
Took my first dose of the COVID-19 vaccine at AIIMS. Remarkable how our doctors and scientists have worked in quick time to strengthen the global fight against COVID-19. I appeal to all those who are eligible to take the vaccine. Together, let us make India COVID-19 free!
It’s great to see India’s leadership in scientific innovation and vaccine manufacturing capability as the world works to end the COVID-19 pandemic @PMOIndia